A simulated patient with newly diagnosed type 2 diabetes (A1C 7.2%, eGFR 80, no cardiovascular disease) asks about first-line drug therapy. Reflecting current Canadian guidance, which agent is the usual first-line pharmacologic choice?
- AGlyburide
- BMetformin
- CInsulin glargine
- DPioglitazone